CCND2 and B-cell chronic lymphocytic leukemia: To address this issue, we analyzed the associations of six polymorphic sites in the CDKN1B and CCND2 genes for p27Kip1 and cyclin D2, respectively (G0/G1 phase regulators involved in cell proliferation and apoptosis) for CLL susceptibility and clinical course.